ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,063Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 231

$563K Total Retail Price of All Prescriptions

Rank: 18 out of 231

568 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
11% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 568 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 568 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 7,632 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 498 488 1 1
SIMVASTATIN 477 450 2 2
LEVOTHYROXINE SODIUM 395 376 3 3
ATORVASTATIN CALCIUM 365 345 4 8
AMLODIPINE BESYLATE 346 324 5 4
FUROSEMIDE 223 209 6 6
OMEPRAZOLE 217 215 7 5
METFORMIN HCL 192 181 8 7
ATENOLOL 182 177 9 11
DIOVAN 153 151 10 27
ALLOPURINOL 148 144 11 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 143 12 22
HYDROCHLOROTHIAZIDE 139 125 13 9
METOPROLOL SUCCINATE 133 133 14 13
DOXAZOSIN MESYLATE 129 118 15 105
SYNTHROID 115 111 16 28
INDAPAMIDE 113 95 17 171
LIPITOR 108 108 18 97
CRESTOR 101 94 19 19
GLIPIZIDE 100 99 20 71
PRAVASTATIN SODIUM 90 86 21 10
QUINAPRIL HCL 88 78 22 183
TRAMADOL HCL 87 78 23 16
SERTRALINE HCL 84 83 24 18
LOSARTAN POTASSIUM 82 68 25 29
FLUTICASONE PROPIONATE 80 77 26 40
LEVOFLOXACIN 70 65 27 64
DIOVAN HCT 68 68 28 84
ZOLPIDEM TARTRATE 59 53 29 14
TAMSULOSIN HCL 57 53 30 30
METFORMIN HCL ER 57 57 30 95
CIPROFLOXACIN HCL 57 55 30 58
CELEBREX 56 54 33 99
NEXIUM 55 55 34 31
ALENDRONATE SODIUM 53 53 35 45
CARVEDILOL 53 50 35 24
METHYLPREDNISOLONE 51 47 37 231
AZITHROMYCIN 50 48 38 32
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.